Gabapentin Capsule
Product Images NDC 82619-143

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82619-143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Creekwood Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-100mg 1000s (Gabapentin 100mg 1000s)

Label for Gabapentin Capsules USP, 100 mg, oral dosage form. The label indicates a package containing 1000 capsules and includes the NDC 82619-142-03. It is labeled for prescription use only (Rx Only) and manufactured by Creekwood Pharmaceuticals LLC. The label also provides storage instructions and a barcode.*

FDA Label Image

Gabapentin-100mg 100s (Gabapentin 100mg 100s)

Gabapentin Capsules USP 100 mg oral capsules label from Creekwood Pharmaceuticals LLC. The label states a quantity of 100 capsules per container and includes storage instructions, prescription dispensing information, and a barcode. The design features blue wave graphics and the Creekwood logo.*

FDA Label Image

Gabapentin-100mg 500s (Gabapentin 100mg 500s)

Gabapentin Capsules USP 100 mg oral capsules packaging label from Creekwood Pharmaceuticals LLC. The label indicates 500 capsules per container and includes dosing and storage information along with a barcode and NDC number 82619-142-02. It states 'Rx Only' and directs pharmacists to provide a Medication Guide with dispensing.*

FDA Label Image

Gabapentin-300mg 1000s (Gabapentin 300mg 1000s)

Gabapentin Capsules USP 300 mg in a bottle packaging label from Creekwood Pharmaceuticals LLC. The label indicates 1000 capsules, oral dosage form, with storage instructions and medication guidance information. The label also includes directions for pharmacists to provide a Medication Guide.*

FDA Label Image

Gabapentin-300mg 100s (Gabapentin 300mg 100s)

Label for Gabapentin Capsules, USP 300 mg by Creekwood Pharmaceuticals LLC. The label indicates the product contains 100 capsules and is for oral use. It includes storage instructions, usage directions, lot and expiration details, and a barcode.*

FDA Label Image

Gabapentin-300mg 500s (Gabapentin 300mg 500s)

Label for Gabapentin Capsules USP 300 mg by Creekwood Pharmaceuticals LLC, containing 500 capsules. The label includes storage instructions, dosage warnings, and a barcode, with the NDC 82619-143-02 visible. It is marked Rx Only and features Creekwood's logo.*

FDA Label Image

Gabapentin-400mg 100s (Gabapentin 400mg 100s)

Label for Gabapentin Capsules, USP 400 mg by Creekwood Pharmaceuticals LLC. The label indicates the product contains 100 capsules with oral dosage form. It prominently displays the strength (400 mg) and includes barcode, storage, dispensing, and medication guide instructions, along with the National Drug Code (NDC 82619-144-01). The label is white with blue and orange design elements.*

FDA Label Image

Gabapentin-400mg 500s (Gabapentin 400mg 500s)

Label for Gabapentin Capsules, USP 400 mg by Creekwood Pharmaceuticals LLC. The label indicates a package containing 500 capsules. It includes storage instructions, a medication guide reminder for pharmacists, the NDC number 82619-144-02, and manufacturer details. The label features a barcode and the Creekwood logo.*

FDA Label Image

Gabapentin-600mg 100s (Gabapentin 600mg 100s)

Label for Gabapentin Tablets USP 600 mg, oral dosage form, containing 100 tablets. The label includes the NDC 82619-145-01 and is produced by Creekwood Pharmaceuticals LLC. It states the product is prescription only and includes storage and dispensing instructions as well as a barcode.*

FDA Label Image

Gabapentin-600mg 500s (Gabapentin 600mg 500s)

Gabapentin Tablets USP 600 mg in a bottle containing 500 tablets. The label indicates the product is Rx only and manufactured for Creekwood Pharmaceuticals LLC, Parsippany, NJ. It includes usage, storage instructions, and a barcode. The product is presented as film-coated oral tablets.*

FDA Label Image

Gabapentin-800mg 100s (Gabapentin 800mg 100s)

Label for Gabapentin Tablets, USP 800 mg by Creekwood Pharmaceuticals LLC. The oral dosage form is available as tablets, packaged as 100 tablets per bottle. The label includes NDC number 82619-146-01, storage instructions, and a barcode.*

FDA Label Image

Gabapentin-800mg 500s (Gabapentin 800mg 500s)

Label for Gabapentin Tablets, USP 800 mg by Creekwood Pharmaceuticals LLC. The label states the package contains 500 tablets, each film-coated containing 800 mg of gabapentin. It includes instructions for pharmacists to provide a Medication Guide to patients and storage information. The label shows the NDC 82619-146-02 and includes a barcode and manufacturer details.*

FDA Label Image

Figure 1 (Image 01)

A line graph comparing mean pain scores over 8 weeks between placebo and gabapentin 3600 mg/day. The x-axis represents time in weeks, and the y-axis shows mean pain scores from 0 to 10. The graph includes a 4-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing mean pain scores over a 7-week period for placebo and two gabapentin dosages (1800 mg/day and 2400 mg/day). The x-axis represents weeks from baseline through a 3-week dose titration period and 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin groups show a greater reduction in mean pain scores over time compared to placebo.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares the percentage of responders in two studies, showing placebo (PBO) versus Gabapentin (GBP) at different doses (3600 mg in Study 1, 1800 mg and 2400 mg in Study 2). The vertical axis represents the percentage of responders from 0% to 100%, with Gabapentin groups having higher responder rates than placebo. Statistical significance is noted with asterisks for p-values less than 0.01 and 0.001.*

FDA Label Image

Image-04 (Image 04)

A formula calculating creatinine clearance (CLCr) based on age, weight, serum creatinine levels, and a factor for female patients. It involves multiplying the difference between 140 and age by weight, dividing by 72 times serum creatinine, and multiplying by 0.85 for females.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin, showing a cyclohexane ring attached to a carbon atom bonded to an amino group (CH2NH2) and an acetic acid group (CH2CO2H).*

FDA Label Image

Image-09 (Image 09)

A scatter plot comparing percentage differences against daily gabapentin doses in mg from three studies labeled as Study a, Study b, and Study c. The x-axis represents daily dose (600 to 1800 mg), and the y-axis shows difference percentage values ranging from 2% to 22%. Data points for each study are marked with corresponding symbols and annotations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.